Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Sharon SMILE |
Documents disponibles écrits par cet auteur (3)
Faire une suggestion Affiner la recherche
Pharmacotherapy in autism spectrum disorder / Sharon SMILE
Titre : Pharmacotherapy in autism spectrum disorder Type de document : Texte imprimé et/ou numérique Auteurs : Sharon SMILE, Auteur ; Evdokia ANAGNOSTOU, Auteur Année de publication : 2015 Importance : p.43-62 Langues : Anglais (eng) Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=271 Pharmacotherapy in autism spectrum disorder [Texte imprimé et/ou numérique] / Sharon SMILE, Auteur ; Evdokia ANAGNOSTOU, Auteur . - 2015 . - p.43-62.
Langues : Anglais (eng)
Index. décimale : AUT-B AUT-B - L'Autisme - Ouvrages généraux et scientifiques Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=271 Exemplaires
Code-barres Cote Support Localisation Section Disponibilité aucun exemplaire Prospective cohort study of vitamin D and autism spectrum disorder diagnoses in early childhood / Yamna ALI in Autism, 23-3 (April 2019)
[article]
Titre : Prospective cohort study of vitamin D and autism spectrum disorder diagnoses in early childhood Type de document : Texte imprimé et/ou numérique Auteurs : Yamna ALI, Auteur ; Laura N. ANDERSON, Auteur ; Sharon SMILE, Auteur ; Yang CHEN, Auteur ; Cornelia M. BORKHOFF, Auteur ; Christine KOROSHEGYI, Auteur ; Gerald LEBOVIC, Auteur ; Patricia C. PARKIN, Auteur ; Catherine S. BIRKEN, Auteur ; Peter SZATMARI, Auteur ; Jonathon L. MAGUIRE, Auteur Article en page(s) : p.584-593 Langues : Anglais (eng) Mots-clés : 25-hydroxyvitamin D autism spectrum disorder early childhood vitamin D Index. décimale : PER Périodiques Résumé : Several studies have suggested an association between vitamin D in childhood and autism spectrum disorder. No prospective studies have evaluated whether lower vitamin D levels precede ASD diagnoses – a necessary condition for causality. The objective of this study was to prospectively evaluate whether vitamin D serum levels in early childhood was associated with incident physician diagnosed ASD. A prospective cohort study was conducted using data from preschool-aged children in the TARGet Kids! practice-based research network in Toronto, Canada, from June 2008 to July 2015. 25-hydroxyvitamin D concentration was measured through blood samples and vitamin D supplementation from parent report. Autism spectrum disorder diagnosis was determined from medical records at follow-up visits. Covariates included age, sex, family history of autism spectrum disorder, maternal ethnicity, and neighborhood household income. Unadjusted and adjusted relative risks and 95% confidence intervals were estimated using Poisson regression with a robust error variance. In this study, 3852 children were included. Autism spectrum disorder diagnosis was identified in 41 children (incidence?=?1.1%) over the observation period (average follow-up time?=?2.5?years). An association between 25-hydroxyvitamin D concentration and autism spectrum disorder was not identified in the unadjusted (relative risk?=?1.04, 95% confidence interval: 0.97, 1.11 per 10?nmol/L increase in 25-hydroxyvitamin D concentration) or adjusted models (adjusted relative risk?=?1.06; 95% confidence interval: 0.95, 1.18). An association between vitamin D supplementation in early childhood and autism spectrum disorder was also not identified (adjusted relative risk?=?0.86, 95% confidence interval: 0.46, 1.62). Vitamin D in early childhood may not be associated with incident physician diagnoses of autism spectrum disorder. En ligne : http://dx.doi.org/10.1177/1362361318756787 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=392
in Autism > 23-3 (April 2019) . - p.584-593[article] Prospective cohort study of vitamin D and autism spectrum disorder diagnoses in early childhood [Texte imprimé et/ou numérique] / Yamna ALI, Auteur ; Laura N. ANDERSON, Auteur ; Sharon SMILE, Auteur ; Yang CHEN, Auteur ; Cornelia M. BORKHOFF, Auteur ; Christine KOROSHEGYI, Auteur ; Gerald LEBOVIC, Auteur ; Patricia C. PARKIN, Auteur ; Catherine S. BIRKEN, Auteur ; Peter SZATMARI, Auteur ; Jonathon L. MAGUIRE, Auteur . - p.584-593.
Langues : Anglais (eng)
in Autism > 23-3 (April 2019) . - p.584-593
Mots-clés : 25-hydroxyvitamin D autism spectrum disorder early childhood vitamin D Index. décimale : PER Périodiques Résumé : Several studies have suggested an association between vitamin D in childhood and autism spectrum disorder. No prospective studies have evaluated whether lower vitamin D levels precede ASD diagnoses – a necessary condition for causality. The objective of this study was to prospectively evaluate whether vitamin D serum levels in early childhood was associated with incident physician diagnosed ASD. A prospective cohort study was conducted using data from preschool-aged children in the TARGet Kids! practice-based research network in Toronto, Canada, from June 2008 to July 2015. 25-hydroxyvitamin D concentration was measured through blood samples and vitamin D supplementation from parent report. Autism spectrum disorder diagnosis was determined from medical records at follow-up visits. Covariates included age, sex, family history of autism spectrum disorder, maternal ethnicity, and neighborhood household income. Unadjusted and adjusted relative risks and 95% confidence intervals were estimated using Poisson regression with a robust error variance. In this study, 3852 children were included. Autism spectrum disorder diagnosis was identified in 41 children (incidence?=?1.1%) over the observation period (average follow-up time?=?2.5?years). An association between 25-hydroxyvitamin D concentration and autism spectrum disorder was not identified in the unadjusted (relative risk?=?1.04, 95% confidence interval: 0.97, 1.11 per 10?nmol/L increase in 25-hydroxyvitamin D concentration) or adjusted models (adjusted relative risk?=?1.06; 95% confidence interval: 0.95, 1.18). An association between vitamin D supplementation in early childhood and autism spectrum disorder was also not identified (adjusted relative risk?=?0.86, 95% confidence interval: 0.46, 1.62). Vitamin D in early childhood may not be associated with incident physician diagnoses of autism spectrum disorder. En ligne : http://dx.doi.org/10.1177/1362361318756787 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=392 A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism / Deepali MANKAD in Molecular Autism, (March 2015)
[article]
Titre : A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism Type de document : Texte imprimé et/ou numérique Auteurs : Deepali MANKAD, Auteur ; Annie DUPUIS, Auteur ; Sharon SMILE, Auteur ; Wendy ROBERTS, Auteur ; Jessica BRIAN, Auteur ; Toni LUI, Auteur ; Lisa GENORE, Auteur ; Dina ZAGHLOUL, Auteur ; Alana IABONI, Auteur ; Peggy Margaret A. MARCON, Auteur ; Evdokia ANAGNOSTOU, Auteur Article en page(s) : p.1-11 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting more than 1% of children. It is characterized by social communication deficits and repetitive behaviors/restricted interests. In the absence of any medications known to improve core symptom domains, parents often use complementary alternative treatments, including omega-3 fatty acid supplements. En ligne : http://dx.doi.org/10.1186/s13229-015-0010-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=277
in Molecular Autism > (March 2015) . - p.1-11[article] A randomized, placebo controlled trial of omega-3 fatty acids in the treatment of young children with autism [Texte imprimé et/ou numérique] / Deepali MANKAD, Auteur ; Annie DUPUIS, Auteur ; Sharon SMILE, Auteur ; Wendy ROBERTS, Auteur ; Jessica BRIAN, Auteur ; Toni LUI, Auteur ; Lisa GENORE, Auteur ; Dina ZAGHLOUL, Auteur ; Alana IABONI, Auteur ; Peggy Margaret A. MARCON, Auteur ; Evdokia ANAGNOSTOU, Auteur . - p.1-11.
Langues : Anglais (eng)
in Molecular Autism > (March 2015) . - p.1-11
Index. décimale : PER Périodiques Résumé : Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting more than 1% of children. It is characterized by social communication deficits and repetitive behaviors/restricted interests. In the absence of any medications known to improve core symptom domains, parents often use complementary alternative treatments, including omega-3 fatty acid supplements. En ligne : http://dx.doi.org/10.1186/s13229-015-0010-7 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=277